Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers N > Headlines for Neuralstem Inc. > News item |
Neuralstem to price public offering of shares with 45-day greenshoe
Underwriter Aegis will help raise funds for general corporate purposes
By Devika Patel
Knoxville, Tenn., Aug. 3 - Neuralstem, Inc. plans to conduct a public offering of common stock, according to a preliminary prospectus supplement filed Friday with the Securities and Exchange Commission. Aegis Capital Corp., the underwriter, has a 45-day greenshoe.
Proceeds will be used for general corporate purposes, including working capital, product development and capital expenditures.
Based in Rockville, Md., Neuralstem develops technologies to transplant human neural stem cells.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.